Immunogenicity and safety of a 2009 pandemic influenza A (H1N1) monovalent vaccine in Chinese...

Por Li, Yan‐Ping, Li, Wei, Liang, Xiao‐Feng, Liu, Yan, Huang, Xiao‐Chun, Li, Chang‐Gui, Li, Rong‐Cheng, Wang, Jun‐Zhi, Wang, Hua‐Qing, Yin, Wei‐Dong
Publicado no Influenza Other Respir Viruses (2012)

A-Part Gel, an adhesion prophylaxis for abdominal surgery: a randomized controlled phase I–II safety study [NCT00646412]

Por Lang, Reinhold, Baumann, Petra, Schmoor, Claudia, Odermatt, Erich K., Wente, Moritz N., Jauch, Karl-Walter
Publicado no Ann Surg Innov Res (2015)

A prospective, randomised, controlled, double-blind phase I-II clinical trial on the safety of A...

Por Lang, Reinhold, Baumann, Petra, Jauch, Karl-Walter, Schmoor, Claudia, Weis, Christine, Odermatt, Erich, Knaebel, Hanns-Peter
Publicado em 2010

Efficacy, safety and tolerability of progesterone vaginal pessaries versus progesterone vaginal gel for luteal phase support after in vitro fertilisation: a randomised controlled trial

Por Saunders, Helen, Khan, Cass, D’Hooghe, Thomas, Magnúsdóttir, Thora Björg, Klingmann, Ingrid, Hrafnsdóttir, Sigrún
Publicado no Hum Reprod (2020)

Safety, tolerability and pharmacokinetics of the fibroblast growth factor receptor inhibitor AZD...

Por Saka, Hideo, Kitagawa, Chiyoe, Kogure, Yoshihito, Takahashi, Yasuo, Fujikawa, Koshi, Sagawa, Tamotsu, Iwasa, Satoru, Takahashi, Naoki, Fukao, Taro, Tchinou, Catherine, Landers, Dónal, Yamada, Yasuhide
Publicado no Invest New Drugs (2017)

Pharmacokinetics, Safety, and Efficacy of Glecaprevir/Pibrentasvir in Adolescents With Chronic Hepatitis C Virus: Part 1 of the DORA Study

Por Jonas, Maureen M., Squires, Robert H., Rhee, Susan M., Lin, Chih‐Wei, Bessho, Kazuhiko, Feiterna‐Sperling, Cornelia, Hierro, Loreto, Kelly, Deirdre, Ling, Simon C., Strokova, Tatiana, del Valle‐Segarra, Antonio, Lovell, Sandra, Liu, Wei, Ng, Teresa I., Porcalla, Ariel, Gonzalez, Yuri Sanchez, Burroughs, Margaret, Sokal, Etienne
Publicado no Hepatology (2019)

Efficacy and safety of ozanimod in multiple sclerosis: Dose-blinded extension of a randomized phase II study

Por Cohen, Jeffrey A, Comi, Giancarlo, Arnold, Douglas L, Bar-Or, Amit, Selmaj, Krzysztof W, Steinman, Lawrence, Havrdová, Eva K, Cree, Bruce AC, Montalbán, Xavier, Hartung, Hans-Peter, Huang, Vivian, Frohna, Paul, Skolnick, Brett E, Kappos, Ludwig
Publicado no Mult Scler (2018)

Phase I Trial of Pyragrel, a Novel Thromboxane Synthetase Inhibitor, to Evaluate the Safety, Tolerability, and Pharmacokinetics in Healthy Volunteers

Por Zou, Chan, Zuo, Xiaocong, Huang, Jie, Hua, Ye, Yang, Shuang, Yang, Xiaoyan, Guo, Can, Tan, Hongyi, Chen, Jun, Chu, Zhaoxing, Pei, Qi, Yang, Guoping
Publicado no Front Pharmacol (2019)

Translation of TRO40303 from myocardial infarction models to demonstration of safety and tolerance in a randomized Phase I trial

Por Le Lamer, Sophie, Paradis, Stéphanie, Rahmouni, Hidayat, Chaimbault, Corinne, Michaud, Magali, Culcasi, Marcel, Afxantidis, Jean, Latreille, Mathilde, Berna, Patrick, Berdeaux, Alain, Pietri, Sylvia, Morin, Didier, Donazzolo, Yves, Abitbol, Jean-Louis, Pruss, Rebacca M, Schaller, Sophie
Publicado em 2014

Evaluation of the safety and immunomodulatory effects of sargramostim in a randomized, double-blind phase 1 clinical Parkinson’s disease trial

Por Gendelman, Howard E., Zhang, Yuning, Santamaria, Pamela, Olson, Katherine E., Schutt, Charles R., Bhatti, Danish, Shetty, Bhagya Laxmi Dyavar, Lu, Yaman, Estes, Katherine A., Standaert, David G., Heinrichs-Graham, Elizabeth, Larson, LuAnn, Meza, Jane L., Follett, Matthew, Forsberg, Erica, Siuzdak, Gary, Wilson, Tony W., Peterson, Carolyn, Mosley, R. Lee
Publicado no NPJ Parkinsons Dis (2017)

Phase I study of the safety and pharmacokinetics of plerixafor in children undergoing a second...

Por Srinivasan, Ashok, Panetta, John C., Cross, Shane, Pillai, Asha, Triplett, Brandon M., Shook, Dave R., Dallas, Mari H., Hartford, Christine, Sunkara, Anusha, Kang, Guolian, Jacobsen, Jeffrey, Choi, John, Leung, Wing
Publicado no Biol Blood Marrow Transplant (2014)

666. Efficacy and Safety of Cefiderocol According to Renal Impairment in Patients With Complicated Urinary Tract Infection (cUTI) in a Phase 2 Study

Por Portsmouth, Simon, Echols, Roger, Machida, Mitsuaki, Camilo Arjona Ferreira, Juan, Ariyasu, Mari, Den Nagata, Tsutae
Publicado no Open Forum Infect Dis (2019)

A dose‐ranging study of ticagrelor in children aged 3‐17 years with sickle cell disease: A 2‐part phase 2 study

Por Hsu, Lewis L., Sarnaik, Sharada, Williams, Suzan, Amilon, Carl, Wissmar, Jenny, Berggren, Anders
Publicado no Am J Hematol (2018)

Phase II Study of Hemithoracic Intensity-Modulated Pleural Radiation Therapy (IMPRINT) As Part...

Por Rimner, Andreas, Zauderer, Marjorie G., Gomez, Daniel R., Adusumilli, Prasad S., Parhar, Preeti K., Wu, Abraham J., Woo, Kaitlin M., Shen, Ronglai, Ginsberg, Michelle S., Yorke, Ellen D., Rice, David C., Tsao, Anne S., Rosenzweig, Kenneth E., Rusch, Valerie W., Krug, Lee M.
Publicado no J Clin Oncol (2016)

Patients’ Perspectives of Surgical Safety Before and After Their Elective Surgeries at King Abdulaziz University Hospital, Jeddah, Saudi Arabia

Por Al-Abbadi, Hatim A, Basharaheel, Hadeel A, Alharbi, Maram R, Alharbi, Hanin A, Sindi, Dalia, Bamatraf, Marwa
Publicado no Cureus (2019)

Efficacy and safety of tocilizumab in patients with polyarticular-course juvenile idiopathic...

Por Brunner, Hermine I, Ruperto, Nicolino, Zuber, Zbigniew, Keane, Caroline, Harari, Olivier, Kenwright, Andrew, Lu, Peng, Cuttica, Ruben, Keltsev, Vladimir, Xavier, Ricardo M, Calvo, Inmaculada, Nikishina, Irina, Rubio-Pérez, Nadina, Alexeeva, Ekaterina, Chasnyk, Vyacheslav, Horneff, Gerd, Opoka-Winiarska, Violetta, Quartier, Pierre, Silva, Clovis A, Silverman, Earl, Spindler, Alberto, Baildam, Eileen, Gámir, M Luz, Martin, Alan, Rietschel, Christoph, Siri, Daniel, Smolewska, Elzbieta, Lovell, Daniel, Martini, Alberto, De Benedetti, Fabrizio
Publicado no Ann Rheum Dis (2015)

Neuroprotective therapy using granulocyte colony-stimulating factor for patients with worsening symptoms of compression myelopathy, part 1: a phase I and IIa clinical trial

Por Sakuma, Tsuyoshi, Yamazaki, Masashi, Okawa, Akihiko, Takahashi, Hiroshi, Kato, Kei, Hashimoto, Mitsuhiro, Hayashi, Koichi, Furuya, Takeo, Fujiyoshi, Takayuki, Kawabe, Junko, Mannoji, Chikato, Kadota, Ryo, Hashimoto, Masayuki, Takahashi, Kazuhisa, Koda, Masao
Publicado em 2011

Cetuximab in combination with irinotecan/5-fluorouracil/folinic acid (FOLFIRI) in the initial treatment of metastatic colorectal cancer: a multicentre two-part phase I/II study

Por Raoul, Jean-Luc, Van Laethem, Jean-Luc, Peeters, Marc, Brezault, Catherine, Husseini, Fares, Cals, Laurent, Nippgen, Johannes, Loos, Anja-Helena, Rougier, Philippe
Publicado em 2009

A phase I/II trial of fixed-dose stereotactic body radiotherapy with sequential or concurrent...

Por Sundahl, Nora, De Wolf, Katrien, Rottey, Sylvie, Decaestecker, Karel, De Maeseneer, Daan, Meireson, Annabel, Goetghebeur, Els, Fonteyne, Valérie, Verbeke, Sofie, De Visschere, Pieter, Reynders, Dries, Van Gele, Mireille, Brochez, Lieve, Ost, Piet
Publicado no J Transl Med (2017)

Efficacy and safety of a fixed-dose combination of mometasone furoate and formoterol fumarate...

Por Tashkin, Donald P, Doherty, Dennis E, Kerwin, Edward, Matiz-Bueno, Carlos E, Knorr, Barbara, Shekar, Tulin, Banerjee, Sibabrata, Staudinger, Heribert
Publicado em 2012